Author/Creator: Şener Dede, Didem - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Şener Dede, Didem

1. A current and comprehensive review of cyclin-dependent kinase inhibitors for the treatment of metastatic breast cancer. (2nd September 2017)

Authors:: Bilgin, Burak; Sendur, Mehmet A.N.; Şener Dede, Didem; Akıncı, Muhammed Bülent; Yalçın, Bülent
Journal:: Current medical research and opinion
Issue:: Volume 33:Number 9(2017)
Page Start:: 1559
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Docetaxel or abiraterone in addition to androgen deprivation therapy in metastatic castration-sensitive prostate cancer. (September 2017)

Authors:: Bilgin, Burak; Şendur, Mehmet AN; Hızal, Mutlu; Akıncı, Muhammed Bülent; Şener Dede, Didem; Yalçın, Bulent
Journal:: Future oncology
Issue:: Volume 13:Number 22(2017)
Page Start:: 1911
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Docetaxel or abiraterone in addition to androgen deprivation therapy in metastatic castration-sensitive prostate cancer. (September 2017)

Authors:: Bilgin, Burak; Şendur, Mehmet AN; Hızal, Mutlu; Akıncı, Muhammed Bülent; Şener Dede, Didem; Yalçın, Bulent
Journal:: Future oncology
Issue:: Volume 13:Number 22(2017)
Page Start:: 1911
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Role of obesity on the efficacy of exemestane plus ovarian suppression in hormone receptor-positive premenopausal breast cancer. (March 2015)

Authors:: Nahit Şendur, Mehmet Ali; Aksoy, Sercan; Bülent Akıncı, Muhammed; Ozdemir, Nuriye; Şener Dede, Didem; Altundag, Kadri; Zengin, Nurullah; Yalçın, Bülent
Journal:: Future oncology
Issue:: Volume 11:Number 6(2015)
Page Start:: 905
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Role of obesity on the efficacy of exemestane plus ovarian suppression in hormone receptor-positive premenopausal breast cancer. (March 2015)

Authors:: Şendur, Mehmet Ali Nahit; Aksoy, Sercan; Bülent Akıncı, Muhammed; Ozdemir, Nuriye; Şener Dede, Didem; Altundag, Kadri; Zengin, Nurullah; Yalçın, Bülent
Journal:: Future oncology
Issue:: Volume 11:Number 6(2015)
Page Start:: 905
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. Role of obesity on the efficacy of exemestane plus ovarian suppression in hormone receptor-positive premenopausal breast cancer. (March 2015)

Authors:: Şendur, Mehmet Ali Nahit; Aksoy, Sercan; Bülent Akıncı, Muhammed; Ozdemir, Nuriye; Şener Dede, Didem; Altundag, Kadri; Zengin, Nurullah; Yalçın, Bülent
Journal:: Future oncology
Issue:: Volume 11:Number 6(2015)
Page Start:: 905
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

7. Targeting the PD-1 pathway: a new hope for gastrointestinal cancers. (3rd April 2017)

Authors:: Bilgin, Burak; Sendur, Mehmet A.N.; Bülent Akıncı, Muhammed; Şener Dede, Didem; Yalçın, Bülent
Journal:: Current medical research and opinion
Issue:: Volume 33:Number 4(2017)
Page Start:: 749
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

8. The current status of adjuvant treatment for high-risk renal cell carcinoma. (October 2017)

Authors:: Hızal, Mutlu; Şendur, Mehmet AN; Bilgin, Burak; Akıncı, Muhammed Bülent; Şener Dede, Didem; Yalçın, Bulent
Journal:: Future oncology
Issue:: Volume 13:Number 23(2017)
Page Start:: 2017
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗